Combined effects of HMG-CoA-reductase inhibition and renin–angiotensin system blockade on experimental atherosclerosis

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

New England Journal of Medicine · 2000 · 8.6K citations · Full text

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever, Björn Dahlöf, Neil R Poulter et al. · The Lancet · 2003 · 3.8K citations

Thrombosis, Hypertension, Cardiovascular Disease +12

Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E

Sunny H. Zhang, Robert L. Reddick, Jorge A. Piedrahita et al. · Science · 1992 · 2.2K citations

Vascular Disease, Pathology, Hyperlipidemia +17

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

Kim Fox · The Lancet · 2003 · 2.1K citations

Coronary Heart Disease, Health Policy, Cardiovascular Disease +9

Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Zorina S. Galis, Jaikirshan Khatri · PubMed · 2002 · 1.8K citations

Vascular Disease, Immunology, Pathology +17